No Data
Ocugen Q1 2024 GAAP EPS $(0.05) Beats $(0.06) Estimate, Sales $1.014M Up From $443.000K YoY
Ocugen Q1 2024 GAAP EPS $(0.05) Beats $(0.06) Estimate, Sales $1.014M Up From $443.000K YoY
Earnings Call Summary | Ocugen(OCGN.US) Q1 2024 Earnings Conference
The following is a summary of the Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript:Financial Performance:Ocugen's R&D expenses for Q1 2024 were $6.8 million, a decrease compared to $10.2 million i
Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript
Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript
Express News | Ocugen Inc Qtrly Shr Loss $0.05
Express News | Ocugen Inc: Ocu400 on Track to Meet 2026 Biologics License Application (Bla) and Market Authorization Application (Maa) Approval Targets
Express News | Ocugen Q1 Net Income USD -11.924 Million
Trytosaveabit : Yes it’s a longer hold! Nice pipeline but kinda far out there! But I like it as well! GL